跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAD+SII - TGA Drug Approval Details
Approvals
/
TGA
/
NAD+SII
Approved
STANDARD
NAD+SII
AUSTRALIAN SINOBIOWAY BIOTECH PTY LTD
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
ea9253c5b40701dd
Company
AUSTRALIAN SINOBIOWAY BIOTECH PTY LTD
Type
Standard
Approval Details
Approval Id
ea9253c5b40701dd
Product Name
NAD+SII
Artg Id
395618
Artg Name
NAD+SII
Sponsor
AUSTRALIAN SINOBIOWAY BIOTECH PTY LTD
Company Detail Path
/organization/australian-sinobioway-biotech-pty-ltd
Artg Date
2022-09-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
ea9253c5b40701dd
Type
Standard
Back to TGA Approvals